Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Scynexis Inc
(NQ:
SCYX
)
1.340
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Scynexis Inc
< Previous
1
2
3
4
Next >
GSK Bets On Scynexis' FDA-Approved Antifungal Drug For Over $500M In Bio Bucks
March 30, 2023
Via
Benzinga
Warner Music Layoffs: What to Know About the Latest WMG Job Cuts
March 30, 2023
Warner Music (WMG) layoffs have the entertainment company cutting 4% of its workforce, or 270 jobs, during economic uncertainty.
Via
InvestorPlace
Why Is EVgo (EVGO) Stock Up 25% Today?
March 30, 2023
EVgo (EVGO) stock is on the rise Thursday following the release of its earnings report for the fourth quarter of the year!
Via
InvestorPlace
Why Is Scynexis (SCYX) Stock Up 69% Today?
March 30, 2023
Scynexis (SCYX) stock is taking off on Tuesday as investors react to news of an exclusive license agreement for Brexafemme.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 30, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
March 27, 2023
Via
Benzinga
SCYNEXIS's Return On Capital Employed Overview
December 13, 2022
Via
Benzinga
Scynexis Looks For Commercial Partner For Its Lead Infection Treatment
October 20, 2022
Via
Benzinga
Scynexis Touts Postive Data For Ibrexafungerp For Vaginal Infections
July 19, 2022
Via
Benzinga
Why Edible Garden Shares Are Trading Lower By Over 26%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
March 22, 2023
Gainers Maxpro Capital Acquisition Corp. (NASDAQ: JMAC) shares jumped 69.6% to $15.01 after dropping 24% on Tuesday.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 22, 2023
Via
Benzinga
Analyst Sees Multiple Chances With Over 300% Upside Potential For This Fungal Infections Stock
March 01, 2023
Via
Benzinga
SCYNEXIS: Q1 Earnings Insights
May 12, 2022
SCYNEXIS (NASDAQ:SCYX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 01, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023
March 01, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
February 06, 2023
We're starting off the week with an overview of the biggest pre-market stock movers traders need to know about for Monday!
Via
InvestorPlace
Stocks That Hit 52-Week Lows On Friday
December 30, 2022
Friday's session saw 75 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
December 28, 2022
On Wednesday, 258 companies hit new 52-week lows.
Via
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...
Via
Benzinga
Looking Into SCYNEXIS's Return On Capital Employed
September 09, 2022
Benzinga Pro data, SCYNEXIS (NASDAQ:SCYX) reported Q2 sales of $1.32 million. Earnings fell to a loss of $13.35 million, resulting in a 144.82% decrease from last quarter.
Via
Benzinga
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
September 08, 2022
Via
Benzinga
Recap Of Monday's Biotech Catalysts - End Of the Day Summary
August 01, 2022
Via
Benzinga
Earnings Scheduled For August 15, 2022
August 15, 2022
Companies Reporting Before The Bell • Edible Garden (NASDAQ:EDBL) is likely to report earnings for its second quarter.
Via
Benzinga
SCYNEXIS Shares Climb As FDA Accepts Filing For Vaginal Yeast Infection Candidate Under Priority Review
August 01, 2022
SCYNEXIS (NASDAQ: SCYX) announced that the U.S. Food and Drug Administration (FDA) has accepted its submission of a supplemental New Drug Application (sNDA) to expand the label of BREXAFEMME...
Via
Benzinga
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
July 21, 2022
Gainers Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Via
Benzinga
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
July 20, 2022
Gainers Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year...
Via
Benzinga
Recap of Tuesday's Biotech Catalysts - End Of The Day Summary
July 19, 2022
The U.S. Food and Drug Administration (FDA) has granted tentative approval to Avadel Pharmaceuticals’ (NASDAQ: AVDL) lead candidate LUMRYZ (FT218) for the treatment of excessive daytime sleepiness...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
May 16, 2022
Gainers Adaptimmune Therapeutics (NASDAQ:ADAP) stock rose 12.7% to $1.6 during Monday's after-market session. The market value of their outstanding shares is at $258.9 million.
Via
Benzinga
The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More
May 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
Earnings Scheduled For May 12, 2022
May 12, 2022
Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.
Via
Benzinga
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.